ECP
LAB icon

Elk Creek Partners’s Standard BioTools LAB Stock Holding History

Elk Creek Partners’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-192,169
Closed -$4.65M – 158
2015
Q2 		$4.65M Buy
192,169
+74,583
+63% +$2.35M 0.42% 104
2015
Q1 		$4.95M Sell
117,586
-41,295
-26% -$1.63M 0.51% 82
2014
Q4 		$5.36M Buy
158,881
+31,873
+25% +$903K 0.69% 53
2014
Q3 		$3.11M Buy
127,008
+32,461
+34% +$913K 0.81% 64
2014
Q2 		$2.78M Buy
+94,547
New +$3.03M 0.76% 76

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Elk Creek Partners's LAB Position: Q3 2015 in Review

Elk Creek Partners sold out of Standard BioTools (LAB) in Q3 2015, closing a stake of 192,169 shares — an estimated $4.65M sold.

Elk Creek Partners first reported a position in LAB in Q2 2014 and held it in 5 quarters. The position peaked at $5.36M in Q4 2014. 109 funds tracked by Wall St. Rank hold LAB as of Q3 2015.

  • Elk Creek Partners reported no remaining Standard BioTools position as of Q3 2015 after selling out during the quarter.
  • Elk Creek Partners sold 192,169 Standard BioTools shares in Q3 2015, an estimated $4.65M.
  • Elk Creek Partners first reported a position in Standard BioTools in Q2 2014 and held it in 5 quarters.
  • Elk Creek Partners's Standard BioTools position peaked at $5.36M in Q4 2014.
  • 109 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2015.

Based on Elk Creek Partners's 13F filing for Q3 2015, filed 12 Nov 2015.